Cherry Hill: Daughter’s opioid death caused by ‘corporate greed’

U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc., which made the powerful opioid believed to have played a role in the death of 32-year-old Sarah Fuller in Camden County last year.

Her mother, Deborah, described listening to an audio recording in whicha drug company representative falsely said she was from Sarah’s doctor’s office and misled a pharmacy benefits managerinto believing that Sarah had breakthrough cancer pain. That’s the only condition that Insys’ fast-acting fentanyl brand, Subsys, was approved to treat.

Read the full story on Philly.com